There were cost pressures related to heat-treated factor product. Linked evidence TYWE0000012 - Letter from Chris J Spry to J D Hague - 14 Dec 1984 Chronology Information Date: 14 December 1984 Chapter/issue Blood Products and Addressing Risk: Viral Inactivation